{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:22:57Z","timestamp":1791091377143,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.juro.2007.07.118","type":"journal-article","created":{"date-parts":[[2007,11,10]],"date-time":"2007-11-10T07:15:37Z","timestamp":1194678937000},"page":"2660-2664","source":"Crossref","is-referenced-by-count":26,"title":["The Expression Level of Ligands for Natural Killer Cell Receptors Predicts Response to Bacillus Calmette-Guerin Therapy: A Pilot Study"],"prefix":"10.1097","volume":"178","author":[{"given":"Vladimir","family":"Yutkin","sequence":"first","affiliation":[{"name":"Department of Urology, Hadassah Hebrew University Medical School, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Pode","sequence":"additional","affiliation":[{"name":"Department of Urology, Hadassah Hebrew University Medical School, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Pikarsky","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hadassah Hebrew University Medical School, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Mandelboim","sequence":"additional","affiliation":[{"name":"Lautenberg Center for General and Tumor Immunology, Hadassah Hebrew University Medical School, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2007.07.118_bib1","first-page":"1762","article-title":"Intravesical bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of bacillus Calmette-Guerin","volume":"47","author":"Ratliff","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2007.07.118_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R","article-title":"Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity","volume":"86","author":"Zhao","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2007.07.118_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00184116","article-title":"Specific binding of bacillus Calmette-Guerin to urothelial tumor cells in vitro","volume":"12","author":"Schneider","year":"1994","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2007.07.118_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.07.118_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0090-1229(86)90055-3","article-title":"Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells","volume":"41","author":"Ratliff","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.juro.2007.07.118_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2007.07.118_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.ju.0000131944.52354.63","article-title":"Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation","volume":"172","author":"Suttmann","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.07.118_bib8","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells","volume":"190","author":"Pende","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.juro.2007.07.118_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0198-8859(99)00162-7","article-title":"The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering","volume":"61","author":"Bottino","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.juro.2007.07.118_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.juro.2007.07.118_bib11","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","article-title":"Recognition of viral hemagglutinins by NKp44 but not by NKp30","volume":"31","author":"Arnon","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.juro.2007.07.118_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.juro.2007.07.118_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ni1190","article-title":"Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus","volume":"6","author":"Arnon","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.juro.2007.07.118_bib14","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.171.12.6891","article-title":"Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma","volume":"171","author":"Doubrovina","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.juro.2007.07.118_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.juro.2007.07.118_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood-2003-05-1716","article-title":"The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46","volume":"103","author":"Arnon","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.juro.2007.07.118_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage t1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.07.118_bib18","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1996.14.6.1778","article-title":"Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression","volume":"14","author":"Kaempfer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2007.07.118_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2003.11.018","article-title":"Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with bacillus Calmette-Guerin (BCG)","volume":"45","author":"Saint","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2007.07.118_bib20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","article-title":"Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy","volume":"161","author":"Zlotta","year":"1999","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707019647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707019647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2007.07.118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:28:00Z","timestamp":1784910480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2007.07.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1016\/j.juro.2007.07.118"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2007.07.118","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}